Tag: #M&A

On March 20, 2026, Swiss pharma giant Novartis announced the acquisition of Pikavation Therapeutics (a subsidiary of Synnovation Therapeutics) to... Read more

In a move to solidify its leadership in the attention-deficit/hyperactivity disorder (ADHD) market, Massachusetts-based Collegium Pharmaceutical has struck a deal... Read more

The strategic transaction is projected to conclude in the second quarter of 2026, signaling a significant expansion for the French... Read more

The Mergers and Acquisitions (M&A) landscape in Vietnam's pharmaceutical sector has seen new developments as Lian SGP Holding Pte. Ltd... Read more

Swiss pharmaceutical giant Novartis AG (NYSE: NVS) has officially announced the completion of its acquisition of Avidity Biosciences, Inc., which... Read more

On February 25, 2026, GSK reached an agreement to acquire the Canadian biotech firm 35Pharma for $950 million. The centerpiece... Read more

Gilead Sciences has entered into a definitive agreement to acquire Arcellx in a deal valued at $7.8 billion. Under the... Read more

On February 13, 2026, Ampersand Capital Partners completed the acquisition of Purna Pharmaceuticals, a Belgium-based CDMO specializing in liquid and... Read more

Eli Lilly has officially announced the acquisition of Orna Therapeutics, a biotech startup specializing in re-engineering immune cells directly inside... Read more